CAML loss causes anaphase failure and chromosome missegregation

od Liu, Yu, Malureanu, Liviu, Jeganathan, Karthik B., Tran, David Dinh, Lindquist, Lonn D., van Deursen, Jan M., Bram, Richard J.
Wydane 2009

A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872

od Galanis, Evanthia, Anderson, S. Keith, Twohy, Erin L., Carrero, Xiomara W., Dixon, Jesse G., Tran, David Dinh, Jeyapalan, Suriya A., Anderson, Daniel M., Kaufmann, Timothy J., Feathers, Ryan W., Giannini, Caterina, Buckner, Jan C., Anastasiadis, Panos Z., Schiff, David
Wydane w Cancer (2019)